Search
for
Sort by
Research 421–450 of 1000+
- Association of insulin-like growth factor 2 Apa1 A820G gene (rs680) polymorphism with polycystic ovarian syndrome
- Comparison of mathematical indices of insulin resistance for clinical application in the four phenotypes of polycystic ovarian syndrome
- Frequency of polycystic ovarian syndrome in women with postadolescent acne
- Polycystic ovarian disease in adult and perimenopausal women
- POLYCYSTIC OVARIAN SYNDROME;
- Prevalence of androgenic alopecia (AGA) in patients with polycystic ovarian syndrome (PCOS) and characterization of associated clinical and biochemical features
- Polycystic ovarian syndrome: Proposal for an evidence -based management plan for an electronic patient record system
- Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
- Drug Therapy in Polycystic Ovarian Syndrome
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Early onset androgenic alopecia: not a cosmetic problem but a sign of life time risk factors. Male phenotypic equivalent of polycystic ovarian syndrome: Is There a Male Phenotype of PCOS
- Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress
- Androgenic alopecia associated with the HSD3B1 (1245a>c) in overweight women with polycystic ovarian syndrome
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review
- Does a male polycystic ovarian syndrome equivalent exist?
- Optimized polycystic ovarian disease prognosis and classification using AI based computational approaches on multi-modality data
- Long-Term Suppression of Testosterone After Treatment with a Gonadotropin-Releasing Hormone Agonist in a Woman with a Presumed Testosterone Secreting Ovarian Tumor
- Use of hair products in relation to ovarian cancer risk
- Male Equivalent Polycystic Ovarian Syndrome: Hormonal, Metabolic, and Clinical Aspects.
- New potential chemotherapy for ovarian cancer — Combined therapy with WP 631 and epothilone B
- COVID-19 in Africa: an ovarian victory?
- Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome
- Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature
- The mechanisms of MicroRNA 21 in premature ovarian insufficiency mice with mesenchymal stem cells transplantation
- Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series
- Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex
- Hyperandrogenism in a Postmenopausal Woman Secondary to Testosterone Secreting Ovarian Stromal Tumor with Acoustic Schwannoma
- Radiomics and radiogenomics in ovarian cancer: a review with a focus on ultrasound applications
- 3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline